says

The landscape of healthcare and policy is constantly evolving, presenting both promising technological advancements and persistent challenges. This week, we delve into the potential of artificial intelligence to revolutionize cardiac risk assessment through incidental findings in CT scans, examine a contentious report from the Trump-era Department of Justice concerning the Biden administration’s enforcement of the FACE Act, and explore the implications of shifts in medical school curricula regarding health equity. Furthermore, recent data highlights the ongoing threat of tetanus despite effective vaccination, and an investigation into academic publishing practices raises questions about transparency and accountability.

AI Poised to Enhance Cardiac Risk Detection in Routine Scans

Each year, an estimated 19 million general chest CT scans are performed in the United States for a variety of reasons, ranging from lung cancer screening to investigating persistent coughs. While radiologists meticulously examine these images for their primary diagnostic purpose, they often identify incidental findings of coronary artery calcium (CAC). The presence and extent of CAC are well-established indicators of cardiovascular disease risk, correlating directly with an individual’s likelihood of experiencing a heart attack or stroke. However, a significant gap exists in clinical practice: an estimated 20% to 40% of this incidentally detected CAC goes unreported, meaning a substantial number of patients may be missing crucial opportunities for early intervention.

In response to this critical oversight, artificial intelligence (AI) is emerging as a powerful solution. Companies like Bunkerhill have developed FDA-authorized algorithms capable of automatically identifying and quantifying incidental calcium in existing chest CT scans. "Without anybody needing to lift a finger on a day-to-day basis, patients can get screened for cardiac diseases," stated Nish Khandwala, CEO of Bunkerhill. This technology promises to transform opportunistic screening, integrating cardiac risk assessment seamlessly into routine diagnostic workflows without requiring additional patient visits or specialized imaging protocols.

The potential impact of such AI-driven opportunistic screening is immense. By flagging patients with elevated CAC, clinicians can proactively initiate preventative measures, such as lifestyle modifications, statin therapy, or further cardiovascular investigations. This proactive approach could significantly reduce the incidence of cardiovascular events, leading to improved patient outcomes and potentially lowering healthcare costs associated with treating advanced heart disease.

Despite the clear technological advancements and the FDA authorizations, widespread adoption of these AI tools by healthcare systems has been slow. Several hurdles stand in the way, including the integration of new AI technologies into existing Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs), as well as physician training and workflow adjustments. Furthermore, the reimbursement landscape for AI-driven diagnostic services remains a complex and evolving area. Health systems need clear financial incentives to invest in and implement these innovative solutions. As Katie Palmer reports for STAT, the challenges of implementing this type of opportunistic screening extend beyond technological integration to encompass economic viability and clinical pathway development. The ultimate success of AI in this domain will depend on overcoming these practical and financial barriers to ensure that the technology translates into tangible benefits for patients.

Trump DOJ Report Alleges Unfair Enforcement of FACE Act by Biden Administration

A recent report issued by the Department of Justice’s Weaponization Working Group, a body established during the Trump administration, asserts that the Biden administration engaged in unfair enforcement of the Freedom of Access to Clinic Entrances (FACE) Act. The report, released yesterday, argues that the Biden DOJ disproportionately prosecuted anti-abortion protestors while allegedly showing leniency towards abortion clinics and pro-choice groups. The FACE Act, enacted in 1994, prohibits the use or threat of physical force, or the obstruction of access, to facilities providing reproductive health services or to individuals exercising their First Amendment right to religious freedom.

The report’s central claim is that the Biden administration weaponized federal law against pro-life advocates. A key piece of data highlighted in the report indicates that the average sentence requested for "peaceful pro-life defendants" was 26.3 months, significantly higher than the 12.3 months requested for "violent pro-abortion defendants." Additionally, the report contends that the Biden DOJ "downplayed" incidents involving attacks on crisis pregnancy centers and religious institutions, suggesting a biased application of the law.

However, an analysis of the report by the law journal Just Security offers a counter-narrative, suggesting that the report omits crucial context. Critics argue that the characterization of "peaceful pro-life defendants" is misleading. The conduct leading to prosecutions of individuals labeled as "peaceful pro-life protestors" has frequently involved serious offenses. These include acts of firebombing, arson, bomb threats, and organized blockades aimed at disrupting the operations of reproductive health clinics. A 2024 report by the Southern Poverty Law Center detailed how "one of the anti-abortion movement’s most effective weapons has been terror," underscoring the violent nature of some protests that have fallen under the purview of the FACE Act.

The debate over the enforcement of the FACE Act highlights the deeply polarized nature of the abortion debate in the United States. While the Trump-era DOJ report seeks to frame the issue as one of selective prosecution, critics argue that it ignores the documented instances of violence and intimidation that have prompted federal intervention. The Just Security analysis suggests that a comprehensive understanding of FACE Act enforcement requires a nuanced examination of the specific conduct involved in each case, rather than broad generalizations about the motivations of protestors or the actions of the Department of Justice. The differing interpretations underscore the challenges in ensuring equitable and impartial application of the law in a politically charged environment.

Medical Schools Face Scrutiny Over Health Equity Education Shifts

Formal accreditation requirements for medical schools to teach about health disparities and equity were only established in 2015. More than a decade later, amidst mounting political pressure, the leading accreditation body for medical education in the United States, the Liaison Committee on Medical Education (LCME), has removed specific language mandating this training from its standards. The accreditation body has replaced the explicit requirement with a broader focus on "structural competency."

This shift has raised significant concerns among medical educators and practitioners who view it as a potential step backward in addressing systemic inequities in healthcare. Physician Uchè Blackstock, writing in a STAT First Opinion essay, argues that "This change isn’t trivial." She elaborates that "The LCME has made this content easier to deprioritize at a moment when its understanding remains essential to clinically competent care." The concern is that by moving away from explicit requirements for teaching health disparities and equity, medical schools may feel less compelled to dedicate sufficient time and resources to these critical topics.

The implications of this change could be far-reaching. Health equity education equips future physicians with the understanding and tools necessary to recognize and address the social, economic, and environmental factors that contribute to disparate health outcomes among different patient populations. Without this foundational knowledge, clinicians may be less adept at identifying implicit biases, understanding the impact of systemic racism on patient health, and advocating for policies that promote equitable access to care.

Blackstock’s own experiences in the emergency room have repeatedly underscored the importance of this training. She points to everyday encounters where a patient’s health is inextricably linked to their socioeconomic status, race, or geographic location. Failing to address these "structural determinants of health" can lead to misdiagnosis, inadequate treatment, and ultimately, poorer health outcomes for marginalized communities. The shift to "structural competency" may offer a pathway to understanding these broader influences, but critics worry that without the explicit mandate for health equity, the focus may become more theoretical and less grounded in the practical realities of patient care and advocacy. The effectiveness of this new framework will likely depend on how medical schools interpret and implement the "structural competency" requirement and whether it truly translates into a deeper understanding of and commitment to achieving health equity.

Hundreds Contract Tetanus Annually Despite Highly Effective Vaccine

A recent analysis by the Centers for Disease Control and Prevention (CDC) of tetanus cases and deaths in the United States from 2009 to 2023 underscores a persistent and preventable public health threat. The study, published in the CDC’s Morbidity and Mortality Weekly Report (MMWR), reveals that at least 402 cases of tetanus were reported across the nation during this period, resulting in 37 fatalities. These figures highlight that despite the availability of a highly effective vaccine, failure to maintain adequate immunity continues to put individuals at risk from this dangerous bacterium, Clostridium tetani, which is ubiquitous in the environment, particularly in soil and animal feces.

The CDC’s findings indicate that a significant proportion of these reported cases occurred in individuals who were either never vaccinated against tetanus, had not completed the full primary vaccination series, or had not received a booster dose within the recommended 10-year timeframe. Crucially, the analysis noted that none of the reported deaths involved individuals who had received three or more doses of a tetanus-containing vaccine, further emphasizing the protective power of vaccination.

The report also identifies a critical gap in clinical practice: missed opportunities for vaccination. It suggests that a substantial number of patients who sought medical attention for wounds that could have led to tetanus exposure should have been offered a tetanus vaccine. Furthermore, approximately three-quarters of these patients should have also been offered tetanus immune globulin (TIG), a passive immunization that provides immediate protection. However, this recommended care was delivered in only a fraction of these cases.

These findings point to a need for enhanced provider education and adherence to established clinical guidelines. The CDC report implicitly suggests that healthcare providers would benefit from refreshing their knowledge and protocols regarding the appropriate management of wounds and the timely administration of tetanus prophylaxis. Bridging this gap in care delivery is essential to preventing future tetanus cases and deaths, especially as the bacterium remains a constant environmental presence. Public health campaigns reinforcing the importance of timely booster shots and encouraging individuals to consult with their healthcare providers about their vaccination status are also vital components of a comprehensive strategy to combat this preventable disease.

Academic Publishing Transparency Under Scrutiny Following Journal’s "Expression of Concern"

The integrity and transparency of academic publishing are under renewed scrutiny following a recent episode involving the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP). Last fall, the journal issued an "expression of concern" regarding a controversial 2001 study that examined a widely prescribed antidepressant. This expression of concern was accompanied by the retraction of the study itself. However, as reported by Ed Silverman in his Pharmalot column, the original study proved to be more readily accessible online than the journal’s subsequent warning.

This situation raises fundamental questions about the effectiveness of academic journals in disseminating crucial information, particularly when that information pertains to the re-evaluation or retraction of influential research. The ease with which the problematic study could be found, contrasted with the difficulty in locating the accompanying expression of concern, suggests a potential deficiency in the communication channels used by academic publishers. It was only after Silverman’s inquiry to the journal and publisher that the expression of concern became more widely discoverable.

This incident is not isolated. The academic publishing world faces ongoing challenges in ensuring that retractions and expressions of concern are as prominent and accessible as the original publications they address. Such warnings are critical for the scientific community and the public, as they signal potential flaws in research methodology, data integrity, or interpretation that could impact clinical practice or future scientific endeavors. When these warnings are obscured or difficult to find, the scientific record can remain misleading, potentially influencing medical decisions and public perception based on compromised research.

The case highlights the broader implications for academic transparency and accountability. It suggests a need for standardized protocols and improved digital infrastructure within academic publishing to ensure that all official communications, especially those related to the integrity of published research, are easily identifiable and accessible. The journey down this "rabbit hole," as Silverman describes it, underscores the importance of diligent investigative journalism in holding academic institutions and publishers to account for their role in maintaining the reliability and trustworthiness of scientific literature. The broader impact extends to researchers, clinicians, and policymakers who rely on the scientific record to inform their work and decisions. Ensuring clear and immediate access to expressions of concern and retractions is paramount to the ongoing health and integrity of the scientific enterprise.